Top Healthcare stocks:
Healthcare shares were generally lower in pre-market trade on Friday.
In healthcare stocks news, Kamada ( KMDA ) is lower after the company announced preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of its proprietary inhaled Alpha-1 Antitrypsin ( AAT ) therapy to treat Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).
And, Abbott ( ABT ) edged lower in recent pre-market trading on Friday after saying it has signed a definitive agreement to buy Latin American pharmaceutical company CFR Pharmaceuticals for approximately $2.9 billion, plus the assumption of debt of approximately $430 million.
ABT closed down to $39.24 Thursday, in a 52-week range of $32.70 - $40.49.
And, Bovie Medical ( BVX ) said late Thursday Q1 sales were $6.5 million, up 14% from a year ago. Adjusted net loss was $0.01 per share, down from a loss of $0.02 last year.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.